Clinical trials recruiting for Crohn's disease
328
Recruiting trials
47
US states with sites
64
Countries
15%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Guselkumab | 7 |
| Infliximab | 7 |
| Ustekinumab | 7 |
| Risankizumab | 6 |
| Vedolizumab | 6 |
| Upadacitinib | 5 |
| Vedolizumab IV | 5 |
| Adalimumab | 4 |
| Cyclophosphamide | 4 |
| Mirikizumab | 4 |
| Afimkibart | 3 |
| Mirikizumab - Intravenous (IV) | 3 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 44 |
| California | 41 |
| Texas | 40 |
| Florida | 34 |
| Ohio | 34 |
| Massachusetts | 31 |
| Pennsylvania | 31 |
| Georgia | 25 |
| Illinois | 24 |
| Michigan | 24 |
| Washington | 24 |
| Missouri | 23 |
Top cities
New York, New York 40Boston, Massachusetts 21Miami, Florida 21Atlanta, Georgia 20Houston, Texas 19Los Angeles, California 19Orlando, Florida 19Tyler, Texas 18San Antonio, Texas 17St Louis, Missouri 17
Self-screener
Recruiting trials
- 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
- A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease
- A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
- A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.
- A Phase 1 Study of ATORM-C in Patients With Crohn's Disease
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
- A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
- A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
- A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
- A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms
- A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
- A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
- A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
- A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis
- A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect and Classify Perianal Fistulas in Patients With Crohn's Disease or Fistulas of Unknown Cause
- A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
- A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
- A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
- A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
- A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
- A Survey of Darvadstrocel in People With Crohn's Disease
- AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
- Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases
- Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
- Argentine Registry of Crohn's Disease and Ulcerative Colitis
- Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
- Autologous Stem Cell Transplant for Crohn's Disease
- Autologous Stem Cell Transplantation for Crohn's Disease
- Behavioral Therapy for Crohn's Disease
- Beta-Hydroxybutyrate Feasibility Treating IBD
- Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
- Biologics and Partial Enteral Nutrition Study
- Biologics for Stricturing Crohn's Diseases
- Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
- CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease
- CEDUR - German IBD Registry
- COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- Cellvizio to Evaluate Margins in Crohn's Ileal Disease
- Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
- Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
- Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
- Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Clostridium Butyricum in Stenosing Crohn's Disease
- Combined Immunosuppression for Pediatric Crohn's Disease
- Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
- Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
- Comparing Hand-sewn (END-TO-END or Kono-S) to Stapled Anastomosis in Ileocolic Resection for Crohn's Disease
- Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)
- Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY
- Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
- Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients
- Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
- Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Related conditions
Trials recruiting for Crohn's disease often also study these conditions. Each links to its own recruiting-trial list.
Ulcerative colitis 288Inflammatory bowel disease 63Inflammatory Bowel Disease (IBD) 29Psoriasis 233Colitis Ulcerative 33Inflammatory Bowel Disease 15Rheumatoid arthritis 314IBD 13IBD (Inflammatory Bowel Disease) 10Crohn's Disease (CD) 7
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Crohn's disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.